QualityStocksNewsBreaks Archives - Page 441 of 1518

MondayNov 21, 2022 1:49 pm

QualityStocksNewsBreaks – CubCrafters Receives SEC Stock Offering Approval, Makes Progress in Plan to Go Public

CubCrafters, a light-sport, experimental, and backcountry aircraft company, announced that it has earned a qualification through the Securities and Exchange Commission (“SEC”) to make a $50 million public stock offering. This recent announcement, which takes the company one step closer to becoming a public company, gives outside investors an opportunity to invest in the company for the first time. According to the announcement, the company anticipates raising the funds from “fans, customers, aviation enthusiasts, the investment community, and the general public.” The company said that first-round investors would be able to purchase shares at $5 per share, with a minimum…

MondayNov 21, 2022 12:46 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Focus on Dementia and Diabetes Featured in New Interview

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in an interview produced by PCG Digital Holdings LLC and published on NewMediaWire. John Docherty, Lexaria’s president and head of research, discussed the company’s efforts to investigate the potential therapeutic utility of its proprietary DehydraTECH(TM)-CBD against dementia and diabetes, two of the world’s largest public health crises. Lexaria recently demonstrated DehydraTECH-CBD’s exceptional safety and tolerability in a human hypertension study, as well as statistically significant lowering of blood pressure over multiple weeks (something that previous studies by others have failed to evidence). Strong connections exist between…

MondayNov 21, 2022 12:22 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis (“RA”), designated as SPU-21, in human synovial tissue surrounding joints and tendons. The three-month study will assess the binding affinity of the peptide in healthy human and RA synovial tissue, with initial data expected during the first quarter of 2023. “SPU-21 was shown to inhibit arthritic progression in a preclinical animal model, so we are proceeding to advance our research into human synovial tissue, where…

MondayNov 21, 2022 11:31 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Q3 2022 Earnings Call

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that it will host its third quarter 2022 earnings call via webcast at 4:30 p.m. ET on Monday, Nov. 28. During the webcast, Flora management will deliver financial and operational results for the third quarter ended Sept. 30, 2022, and provide updates on the company’s commercial wholesale operations, house of brands and life sciences division strategies. Following the presentation, Flora management will open the call to analysts, media and investors in a Q&A format. Interested parties should visit https://ibn.fm/j1zip to register for…

FridayNov 18, 2022 3:42 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc.’s SmartGreen(TM) Is Total Building Energy ‘Makeover’

GeoSolar Technologies is a Colorado-based company dedicated to Net-Zero initiatives by helping residents and businesses reduce carbon emissions and achieve energy independence. “The company’s SmartGreen(TM) Home systems harness the power of the sun and earth to heat and cool buildings, charge electric vehicles, and run electric appliances while purifying the air and maximizing energy efficiency… With an eye on global Net-Zero goals, GeoSolar’s technology empowers building owners to act locally by leveraging a mix of renewable energy sources. The company’s patent pending SmartGreen(TM) Home system is a total building energy ‘makeover’ that comprises solar panels and geothermal ground loops to…

FridayNov 18, 2022 3:01 pm

QualityStocksNewsBreaks – REZYFi Inc. Leading Industry with Diversified Approach to Real Estate Lending Sector

REZYFi, a growth mortgage origination and specialized financing company servicing the needs of both traditional and non-traditional consumers and businesses, is uniquely positioned as the first cannabis mortgage banker in the United States. “REZYFi operates through two wholly owned subsidiaries – REZYFi Lending and ResMac, Inc. REZYFi Lending leverages a wide network to offer options such as 15- to 30-year fixed-rate, FHA, VA, and jumbo loans and reverse and adjustable-rate mortgages. The company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the company’s launch of a high-margin…

FridayNov 18, 2022 12:29 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Treatment Poised to Provide Reprieve to Millions of Patients

Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has been shown to substantially increase the bioavailability of active pharmaceutical ingredients (‘APIs’). In human studies, Lexaria has shown that DehydraTECH-CBD not only increases the amount of CBD in the blood by as much as 317% but also reduces blood pressure and arterial stiffness,” a recent article reads. “Lexaria hopes to prove, through registered clinical trials, that its DehydraTECH-CBD formulation has an acceptable safety and tolerability…

FridayNov 18, 2022 10:38 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price of $3.30 per share or prefunded warrant. In addition, the agreement notes that INM will issue unregistered preferred investment options to the same investors; those options include purchasing up to 3,272,733 additional common shares. According to the announcement, the company anticipates the private placement, which…

FridayNov 18, 2022 10:14 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Discusses Next-Level Technology on Stock Day Podcast

Mullen Automotive (NASDAQ: MULN), a Southern California-based company building the next generation of premium electric vehicles (“EVs”) that are affordable and built entirely in the U.S., was featured on a recent episode of the Stock Day Podcast. Mullen’s CEO David Michery joined Stock Day host Everett Jolly to discuss the company’s milestones, partnerships, strategic acquisitions, deliverables, and the successful debut of Mullen’s first electric crossover. The EV crossover, for which the company is currently accepting pre-orders and expected to arrive on the market in 2024, was recently recognized for its design and state-of-the-art PERSONA technology. “The response has been overwhelming,”…

Site Search

Company Search

Category: QualityStocksNewsBreaks